BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6161253)

  • 1. Cytotoxic and antitumor properties of bleomycin and several of its metal complexes.
    Rao EA; Saryan LA; Antholine WE; Petering DH
    J Med Chem; 1980 Dec; 23(12):1310-8. PubMed ID: 6161253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells.
    Lyman S; Ujjani B; Renner K; Antholine W; Petering DH; Whetstone JW; Knight JM
    Cancer Res; 1986 Sep; 46(9):4472-8. PubMed ID: 2425953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the chemical reactivity of copper bleomycin.
    Antholine WE; Solaiman D; Saryan LA; Petering DH
    J Inorg Biochem; 1982 Oct; 17(2):75-94. PubMed ID: 6184448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative binding properties of metallobleomycins with DNA 10-mers.
    Li W; Zhao C; Xia C; Antholine WE; Petering DH
    Biochemistry; 2001 Jun; 40(25):7559-68. PubMed ID: 11412110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strand breakage in isolated nuclei subjected to bleomycin or hydrogen peroxide.
    Byrnes RW; Petering DH
    Biochem Pharmacol; 1994 Aug; 48(3):575-82. PubMed ID: 7520697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin.
    Lin PS; Kwock L; Hefter K; Misslbeck G
    Cancer Res; 1983 Mar; 43(3):1049-53. PubMed ID: 6186368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of flavonoids and ascorbate on enhancement in DNA degradation induced by a bleomycin-Fe complex.
    Sugihara N; Kaneko A; Furuno K
    Free Radic Res; 2005 Mar; 39(3):237-44. PubMed ID: 15788228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of bleomycin in iron- and copper-deficient cells.
    Lyman S; Taylor P; Lornitzo F; Wier A; Stone D; Antholine WE; Petering DH
    Biochem Pharmacol; 1989 Dec; 38(23):4273-82. PubMed ID: 2480795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents.
    Lazo JS; Schisselbauer JC; Herring GM; Kennedy KA
    Cancer Commun; 1990; 2(2):81-6. PubMed ID: 1695520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical, biochemical, and cellular properties of copper and iron bleomycins.
    Solaiman D; Rao EA; Petering DH; Sealy RC; Antholine WE
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1519-21. PubMed ID: 94054
    [No Abstract]   [Full Text] [Related]  

  • 12. Bleomycin inhibition of angiotensin-converting enzyme activity from serum, lungs, and cultured pulmonary artery endothelial cells.
    Lazo JS; Lynch TJ; McCallister J
    Am Rev Respir Dis; 1986 Jul; 134(1):73-8. PubMed ID: 2425674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antitumor activity of bleomycin by benzamide in vitro and in vivo.
    Sakamoto H; Kawamitsu H; Miwa M; Terada M; Sugimura T
    J Antibiot (Tokyo); 1983 Mar; 36(3):296-300. PubMed ID: 6187722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage.
    Hoehn ST; Junker HD; Bunt RC; Turner CJ; Stubbe J
    Biochemistry; 2001 May; 40(20):5894-905. PubMed ID: 11352724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ultraviolet irradiation on the antitumor activity of bleomycin.
    Mori H
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1400-2. PubMed ID: 1697512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of cytotoxicity of bleomycin by dithiocarbamates: formation of bis(dithiocarbamato) cu(II).
    Ujjani B; Lyman S; Winkelmann D; Antholine W; Petering DH; Jones MM
    J Inorg Biochem; 1990 Jan; 38(1):81-93. PubMed ID: 1692085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
    He NG; Zhang HQ; Wang RH; Yang XL; Xue SB
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the cytostatic effect of bleomycin on L5178y mouse lymphoma cells by pepleomycin.
    Müller WE; Geisert M; Zahn RK; Maidhof A; Bachmann M; Umezawa H
    Eur J Cancer Clin Oncol; 1983 May; 19(5):665-70. PubMed ID: 6191987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of bleomycin cytotoxicity by polyhydric alcohols.
    Suzuki T; Kohda K; Kawazoe Y
    Anticancer Res; 1990; 10(1):97-103. PubMed ID: 1692198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin: revival of an old drug.
    Mir LM; Tounekti O; Orlowski S
    Gen Pharmacol; 1996 Jul; 27(5):745-8. PubMed ID: 8842674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.